NCT04862585 2025-08-20
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Ohio State University Comprehensive Cancer Center
Phase 2/3 Completed
Clinical Trials
7 trialsNCT03145012 2023-02-08
Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity
Nova Scotia Health Authority
Phase 4 Completed
NCT01287520 2019-02-25
A Study of LY2090314 in Patients With Advanced or Metastatic Cancer
Eli Lilly and Company
Phase 1 Completed
NCT01332630 2018-09-20
TPI 287 in Breast Cancer Metastatic to the Brain
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01539655 2017-05-02
Vandetanib
Sanofi
Phase 1 Completed
NCT02441894 2017-01-24
PEGAZUS
Sanofi
Phase 4 Completed
NCT00030992 2012-08-20
BMS 247550 to Treat Kidney Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed